Literature DB >> 22992393

Cystic fibrosis: experience in one institution.

Ling-Chun Liu1, Shyh-Dar Shyur2, Szu-Hung Chu1, Li-Hsin Huang1, Yu-Hsuan Kao1, Wei-Te Lei1, Chieh-Han Cheng1, Chia-Yi Lo1, Chen-Kuan Chen1, Li-Ching Fang1.   

Abstract

Cystic fibrosis (CF) is one of the most common autosomal recessive inherited disorders among Caucasians. Comparatively, it is considered to be a rare disease among Asians. To date, only a few cases of Taiwanese CF have been published. We report four CF cases from three families. Case 1 was the first report of CF associated with a homozygosity for the CF transmembrane conductance regulator gene (CFTR gene) mutation 3849+10kb C->T in a Taiwanese patient. Cases 2 and 3 had heterozygous c. 1898+5 G->T and heterozygous p. I1023R (novel mutation) for the CFTR gene mutation. Case 4 was homozygous for the CFTR gene mutation R553X being reported in 2005 and complicated with cor pulmonale. These four patients had received 300 mg bid aerosolized tobramycin treatment every other month.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Keywords:  Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator gene (CFTR gene); Taiwan

Mesh:

Substances:

Year:  2012        PMID: 22992393     DOI: 10.1016/j.jmii.2012.06.005

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  2 in total

1.  A Case of Cystic Fibrosis With a Rare Mutation (3849 + 10 kbC > T) and Normal Sweat Chloride Levels.

Authors:  Taha Resid Ozdemir; Ali Kanik
Journal:  Iran J Pediatr       Date:  2015-04-18       Impact factor: 0.364

2.  CFTR founder mutation causes protein trafficking defects in Chinese patients with cystic fibrosis.

Authors:  Gordon K C Leung; Dingge Ying; Christopher C Y Mak; Xin-Ying Chen; Weiyi Xu; Kit-San Yeung; Wai-Lap Wong; Yoyo W Y Chu; Gary T K Mok; Christy S K Chau; Jenna McLuskey; Winnie P T Ong; Huey-Yin Leong; Kelvin Y K Chan; Wanling Yang; Jeng-Haur Chen; Albert M Li; Pak C Sham; Yu-Lung Lau; Brian H Y Chung; So-Lun Lee
Journal:  Mol Genet Genomic Med       Date:  2016-11-13       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.